CRELD2 and metabolic dysfunction-associated steatohepatitis: Recently, cysteine-rich with EGF-like domain 2 (CRELD2) has been uncovered as a novel ER stress-induced chaperon that holds the promise to regulate non-alcoholic steatohepatitis (NASH) [4].